Cefixime Capsules Manufacturer & Exporter

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva Wellness LLP produces Cefixime Capsules for bacterial diseases involving the respiratory tract, urinary system, gastrointestinal tract, and ENT region. The formulation is widely prescribed in typhoid fever, bronchial infections, urinary tract infections, and bacterial throat conditions requiring third-generation cephalosporin therapy.

Cefixime blocks bacterial cell wall formation and helps eliminate susceptible gram-positive and gram-negative organisms responsible for infectious complications. As a recognized Cefixime Capsules Manufacturer in India, Genliva Wellness LLP develops oral cephalosporin capsule formulations with dependable antibacterial activity and consistent pharmaceutical quality.

Known as a Broad Spectrum Antibiotic Exporter, Genliva Wellness LLP supplies oral cephalosporin formulations to pharmaceutical distributors and global healthcare procurement markets.

Cefixime Capsules are designed for advanced oral cephalosporin antibacterial therapy.

Third-generation cephalosporin capsule formulation
Suitable for enteric and respiratory infections
Supports broad antibacterial coverage
Optimized capsule formulation for oral administration
Manufactured using high-quality pharmaceutical ingredients
Intended for outpatient antibacterial therapies

This formulation is commonly prescribed for bacterial infection treatment.

Treatment of typhoid fever
Management of urinary tract infections
Used in bronchial and throat infections
Prescribed in gastrointestinal bacterial disorders
Supports control of susceptible bacterial organisms
Used in oral cephalosporin treatment regimens

Cefixime Capsules provide broad antibacterial coverage for common bacterial illnesses.

Useful in typhoid and respiratory infection care
Helps manage urinary bacterial conditions effectively
Supports bacterial eradication in outpatient therapies
Convenient oral capsule administration
Provides extended cephalosporin antibacterial activity